Loading organizations...
§ Venture Capital · San Francisco, CA, USA
Early-stage venture capital fund investing in startups innovating in women's health and wellness, focused on science-backed solutions.
Coyote Ventures is a San Francisco Bay Area-based early-stage venture capital fund that provides capital to startups developing products in the women's health and wellness sectors. The firm specifically targets science-backed companies addressing medical conditions that solely, disproportionately, or differently affect women across the United States and Canada. Operating primarily as a Fund I vehicle within a niche market of approximately ten dedicated women's health funds, the firm executes pre-seed, seed, and Series A investments. Coyote Ventures typically deploys initial capital with check sizes ranging from $100,000 to $500,000, and occasionally leads financing rounds for its portfolio companies. The organization's investment portfolio features several recognizable consumer, biotechnology, digital health, and healthcare brands, including Hera Biotech, Impossible Foods, Maude, Opentrons, and The Flex Company. Coyote Ventures was founded in 2022 by General Partner Jessica Karr.
Key people at Coyote Ventures.
Coyote Ventures was founded in 2021 by Priyanka Vaidya (Co-Founder and CPO).
Coyote Ventures has 7 tracked investments across 7 companies. The latest tracked deal is $92.0M Seed in Malama Health in March 2026.
Key people at Coyote Ventures.
Coyote Ventures is an early-stage venture capital firm founded in 2021 that invests primarily in seed and pre-seed digital health startups focused on improving health outcomes for traditionally overlooked populations, especially women. Their mission centers on advancing health equity by backing companies addressing a broad spectrum of health challenges, including women’s health conditions like endometriosis, breast cancer, and maternal health, as well as broader social and structural health barriers. They emphasize digital platforms designed with women in mind but maintain a wider health equity lens that includes physical, mental, financial, and community health. Their portfolio companies have collectively generated significant revenue and measurable health impacts, demonstrating strong growth momentum and influence in the health tech ecosystem[1][2][5].
Coyote Ventures was launched in 2021 by Jessica Karr, a scientist-turned-investor, who leads the firm as General Partner. The firm was founded on the belief that investing in companies optimizing health for overlooked populations offers both impactful social outcomes and attractive financial returns. The focus evolved from traditional women’s health to a broader health equity framework, encompassing intersecting disparities across race, geography, and socioeconomic status. The firm targets founders with relevant health tech or buyer experience, often second-time entrepreneurs, and looks for early traction such as MVPs or pilot contracts. This approach reflects a deep understanding of the complex healthcare landscape and the underinvestment in conditions disproportionately affecting women and marginalized groups[1][3][4].
Coyote Ventures rides the growing trend of health equity and women’s health innovation, a sector gaining national momentum with increased policy attention and funding (e.g., White House Initiative on Women’s Health Research, ARPA-H investments). The timing is critical as chronic conditions disproportionately affect marginalized populations, and there is a recognized gap in venture capital addressing these needs. By focusing on digital platforms and data-driven solutions, Coyote Ventures leverages market forces favoring scalable, tech-enabled healthcare innovations. Their influence extends beyond capital, fostering a more inclusive startup ecosystem that elevates diverse leadership and addresses systemic health disparities[1][2][3].
Looking ahead, Coyote Ventures is positioned to deepen its impact as health equity becomes a central theme in healthcare innovation and policy. The firm is likely to expand its portfolio within digital health and related fintech and insurtech solutions that intersect with wellbeing. Trends such as personalized care, affordability in fertility and maternal health, and addressing chronic conditions will shape their investment focus. As private capital increasingly leads health equity efforts, Coyote Ventures’ role as a pioneer and advocate for overlooked populations will likely grow, potentially influencing broader industry standards and funding priorities[2][3][5]. Their commitment to diverse, female-led startups and comprehensive health definitions ensures they remain at the forefront of this evolving landscape.
